Impact of AI-Generated ADC Maps on Computer-Aided Diagnosis of Prostate Cancer: A Feasibility Study

人工智能生成的ADC图对前列腺癌计算机辅助诊断的影响:一项可行性研究

阅读:2

Abstract

RATIONALE AND OBJECTIVES: To evaluate the impact of AI-generated apparent diffusion coefficient (ADC) maps on diagnostic performance of a 3D U-Net AI model for prostate cancer (PCa) detection and segmentation at biparametric MRI (bpMRI). MATERIAL AND METHODS: The study population was retrospectively collected and consisted of 178 patients, including 119 cases and 59 controls. Cases had a mean age of 62.1 years (SD=7.4) and a median prostate-specific antigen (PSA) level of 7.27ng/mL (IQR=5.43-10.55), while controls had a mean age of 63.4 years (SD=7.5) and a median PSA of 6.66ng/mL (IQR=4.29-11.30). All participants underwent 3.0 T T2-weighted turbo spin-echo MRI and high b-value echo-planar diffusion-weighted imaging (bpMRI), followed by either prostate biopsy or radical prostatectomy between January 2013 and December 2022. We compared the lesion detection and segmentation performance of a pretrained 3D U-Net AI model using conventional ADC maps versus AI-generated ADC maps. The Wilcoxon signed-rank test was used for statistical comparison, with 95% confidence intervals (CI) estimated via bootstrapping. A p-value <0.05 was considered significant. RESULTS: AI-ADC maps increased the accuracy of the lesion detection AI model, from 0.70 to 0.78 (p<0.01). Specificity increased from 0.22 to 0.47 (p<0.001), while maintaining high sensitivity, which was 0.94 with conventional ADC maps and 0.93 with AI-ADC maps (p>0.05). Mean dice similarity coefficients (DSC) for conventional ADC maps was 0.276, while AI-ADC maps showed a mean DSC of 0.225 (p<0.05). In the subset of patients with ISUP≥2, standard ADC maps demonstrated a mean DSC of 0.282 compared to 0.230 for AI-ADC maps (p<0.05). CONCLUSION: AI-generated ADC maps can improve performance of computer-aided diagnosis of prostate cancer.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。